FGEN
FibroGen Inc
Price:  
5.25 
USD
Volume:  
71,444.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FGEN Fair Value

-341.03 %
Upside

What is the fair value of FGEN?

As of 2025-07-03, the Fair Value of FibroGen Inc (FGEN) is -12.65 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.25 USD, the upside of FibroGen Inc is -341.03%.

Is FGEN a good investment?

With the market price of 5.25 USD and our fair value calculation, FibroGen Inc (FGEN) is not a good investment. Investing in FGEN stocks now will result in a potential loss of 341.03%.

Note: valuation result may not be accurate due to the company's negative EPS.

5.25 USD
Stock Price
-12.65 USD
Fair Price
FAIR VALUE CALCULATION

FGEN Fair Value

Peter Lynch's formula is:

FGEN Fair Value
= Earnings Growth Rate x TTM EPS
FGEN Fair Value
= 5.00 x -2.53
FGEN Fair Value
= -12.65

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -189.30 -290.00 -293.70 -284.23 -47.58 -220.96
YoY growth -145.84% -53.20% -1.28% 3.22% 83.26% -22.77%

FGEN Fair Value - Key Data

Market Cap (mil) 20.76
P/E
Forward P/E
EPS -2.53
Avg earnings growth rate -22.77%
TTM earnings -10.01